Xerox Holdings Corporation — Form 8-K Summary
Business context and reporting period
Filed November 5, 2019, the Form 8-K reports a restructuring of Xerox’s strategic sourcing relationship with FUJIFILM Holdings Corporation and related agreements involving Fuji Xerox Co., Ltd. (FX) and Xerox International Partners (XIP). This is a transaction-focused filing and does not provide quarterly or annual operating results for a reporting period.
Key transaction terms and financial items
- Xerox’s indirect 25% equity interest in FX will be transferred through a share buyback and subsequent sale. Xerox Limited is to receive $769.89 million from the FX share buyback, followed by a $1.43011 billion purchase price for the remaining interest sold to FUJIFILM Asia Pacific, subject to an adjustment for specified dividends.
- Xerox will sell its indirect 51% partnership interest in XIP for $23 million.
- FX will pay Xerox $100 million for a two-year transition-period license to continue using Xerox trademarks, subject to quality-control requirements.
- FX will pay Xerox a one-time $77 million upfront fee for an OEM license covering certain named original equipment manufacturers.
- The filing does not provide revenue, profit, cash flow, operating margin, debt, liquidity, or earnings guidance metrics.
Material changes versus the prior comparable period
- The agreements are intended to simplify the Xerox-FUJIFILM relationship and establish a new strategic sourcing structure.
- Xerox will exit its equity interest in FX and its 51% interest in XIP, while retaining specified economic benefits through trademark, intellectual-property, OEM, and related licensing arrangements.
- The Master Program Agreement was amended to remove certain change-of-control termination provisions and extend certain product-specific supply arrangements.
- The parties agreed to dismiss with prejudice Fujifilm’s pending litigation against Xerox and release related claims.
Outlook, contingencies, and risks
- The FX transaction was expected to close November 8, 2019, subject to customary conditions and regulatory requirements.
- If Japanese FEFTA approval was not received by November 5, the share buyback could proceed November 8, while the remaining purchase would occur after approval. If approval remained outstanding by March 24, 2020, the parties contemplated an alternative structure or closing by March 30, 2020.
- The XIP sale and ancillary agreements are generally conditioned on consummation of the FX transaction and satisfaction or waiver of specified conditions.
- The technology and ancillary amendments become effective upon the specified effectiveness event, with alternative timing provisions if regulatory approval or legal restrictions delay implementation.
- Management identified risks including failure to satisfy closing conditions, delays or failure to obtain regulatory approvals, termination rights, disruption from the transaction announcement, and potential litigation.
Most important facts for investors to verify
- Whether the FX share buyback and subsequent sale closed on the stated or revised timetable.
- The final cash proceeds received by Xerox, including any dividend-related purchase-price adjustment.
- Whether the $23 million XIP sale and the $100 million trademark and $77 million OEM license payments were completed and when they were recognized.
- The accounting treatment, gain or loss, tax effects, and balance-sheet impact of disposing of the FX and XIP interests.
- The continuing commercial and supply obligations under the amended technology and Master Program Agreements.
- The final status and effect of the dismissal and release of the Fujifilm litigation.